Ophthalmic Drugs Market Size, Share, By Product Type (Prescription Drugs and Over The Counter Drugs), Drug Type (Branded Drugs and Generic Drugs), Disease Indication (Dry Eye, Glaucoma, Infection/Inflammation, Retinal Disorders, and Others), Route of Administration (Topical, Local Ocular, and Systemic), Dosage Form (Gels, Eye Solutions and Suspension, Capsules and Tablets, Eye Drops, and Others), Therapeutic Class (Anti-inflammatory Drugs, Anti-infective Drugs, Anti-glaucoma Drugs, Anti-allergy Drugs, Anti-VEGF Agents, and Others), Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Independent Pharmacies and Others), and Region - Trends, Analysis, and Forecast till 2035

Report Code: PMI67019 | Publish Date: March 2024 | No. of Pages: 178

Global Opthalmic Drugs Market Market Trends

Rising Aging Population is stimulating the Market Augmentation

The increasing aging population is stimulating the ophthalmic drugs market augmentation due to the increased prevalence of age-related eye diseases, which includes, glaucoma, macular degeneration, and cataracts, and specific drug treatments needed for these age related diseases. Moreover, the growing awareness about eye health and the importance of early detection and treatment, also contribute significantly to the market growth.